|
|
Investigation and analysis of community residents’ cognition and demand for genetic testing technology services in Nanning |
QIN Rong GUAN Yanqiu HUANG Fen |
School of Information and Management, Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning 530021, China |
|
|
Abstract Objective To understand the cognitive status, demand willingness, and influencing factors of community residents on genetic testing technology services in Nanning, so as to provide reference for improving population health management strategies and developing large health industry. Methods A field questionnaire survey was conducted among 3 378 community residents in 16 communities of Nanning from March to December 2019 by convenience sampling method. Results 39.72% of community residents had not heard of genetic testing technology services. There were statistically significant differences in the cognition of gene testing technology service among community residents with different gender, age, marital status, education level, monthly income, and suffered from chronic diseases (P<0.05). Logistic regression analysis showed that the community residents with college/bachelor degree below had lower cognition on the service of gene testing technology (OR<1, P<0.05). 2 468 residents (73.06%) indicated that they were willing to receive genetic testing services, the most concerned gene testing for disease susceptibility was malignant tumors, and the most desired follow-up service was preventive measures for susceptible diseases. The main reasons for residents’ reluctance to accept genetic testing services were high cost (542 residents, 59.56%) and fear of privacy disclosure (342 residents, 37.58%). Conclusion Community residents have a low awareness of genetic testing technology services, but the potential demand is larger. It is suggested to strengthen the knowledge popularization of genetic testing technology services, give full play to the professional role of medical personnel, provide personalized health management guidance for community residents, and promote the development of large health industry.
|
|
|
|
|
[1] 许林东,张伟,许林勇,等.基因检测服务在医学中的应用[J].中国现代医学杂志,2011,21(16):1888-1891,1894.
[2] 董聪.服务于临床基因检测报告的精准医学知识库与应用技术研究[D].杭州:浙江大学,2020.
[3] 田琳,孙金海.基于基因检测的国人乳腺癌风险人群健康管理近期效果评估[J].中国卫生标准管理,2017,8(23):3-4.
[4] 杨春.浅谈新冠肺炎疫情对基因检测服务行业的影响[J].就业与保障,2020(14):193-194.
[5] 广西壮族自治区民政厅.广西大健康产业发展规划(2021— 2025年)[EB/OL].(2021-10-15)[2022-5-25].http://mzt.gxzf.gov.cn/gxmzsswghjd/t10758667.shtml.
[6] 张竹.中国人群静脉血栓栓塞症患病现状及易感基因研究[D].北京:北京协和医学院,2020.
[7] 李金涛,杨磊,谭晓华,等.杭州市下城区社区居民对个体化医疗服务的需求意愿及其影响因素研究[J].中国全科医学,2010,13(31):3559-3561.
[8] 钟璇.基因检测技术在肿瘤免疫检查点抑制剂应用中的研究进展[J].黑龙江科学,2021,12(18):74-75.
[9] Lin Z,Xie L,Chen Y. 877P Genetic testing and results in Chinese gynecological tumour patients [J]. Ann Oncol,2020, 31:644.
[10] 李萌辉,刘俊田.BRCA1/2基因检测在恶性肿瘤中的应用[J].中国肿瘤临床,2019,46(7):361-365.
[11] 关瑞娟,李凌,晏鑫,等.基因检测在糖尿病视网膜病变中的研究新进展[J].国际眼科杂志,2020,20(11):1913- 1915.
[12] 康建华,冯绍华,杨立顺.基因检测在2型糖尿病中研究进展[J].生物医学工程与临床,2019,23(5):622-625.
[13] 王晓艳,陈临琪,孙辉,等.儿童糖尿病基因检测研究进展[J].中国实用儿科杂志,2019,34(6):523-526.
[14] Somasegar S,Hoppenot C,Kuchta K,et al. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers [J]. Gynecol Oncol,2021,163(2):220-228.
[15] Butz H,Blair J,Patócs A. Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes [J]. Endocrine,2021,71(3):641-652.
[16] Mark JR,McDougall C,Giri VN. Genetic testing guidelines and education of health care providers involved in prostate cancer care [J]. Urol Clin,2021,48(3):311-322.
[17] Bruni AC,Bernardi L,Maletta R. Evolution of genetic testing supports precision medicine for caring Alzheimer’s disease patients [J]. Curr Opin Pharmacol,2021,60,275-280.
[18] 张春美.DNA的伦理地位[M].上海:上海书店出版社,2006.
[19] 王晓迪.社区居民健康管理及治未病与健康管理服务需求分析[D].杭州:杭州师范大学,2013.
[20] 尚文茹,祝雯珺,杜炎秋,等.西南地区产妇对无创基因检测的知晓情况、支付意愿及满意度研究[J].中国妇幼卫生杂志,2020,11(6):9-15.
[21] 石磊.杭州市三级医院基因检测服务现状及对策研究[D].杭州:杭州师范大学,2012.
[22] 李金涛,杨磊,谭晓华,等.卫生机构对开展基因检测服务所持态度的调查研究[J].社区医学杂志,2010,8(9):4-6.
[23] 林凌青,刘莉莉.厦门市医疗机构开展基因检测服务现况[J].海峡预防医学杂志,2020,26(4):89-92.
[24] 廖庆宏.健康管理中心基因体验的营销策略研究[D].成都:电子科技大学,2014.
[25] 牛玉捷,杨幼萌,黎雅娟,等.长沙市基因检测相关知识态度调查及其影响因素分析[J].实用预防医学,2015, 22(1):13-16.
[26] 李鲁.社会医学[M].3版.北京:人民卫生出版社,2007.
[27] Tischler J,Crew KD,Chung WK. Cases in Precision Med- icine:The Role of Tumor and Germline Genetic Testing in Breast Cancer Management [J]. Ann Intern Med,2019,171(12):925.
[28] 郭清.健康管理学概论[M].北京:人民卫生出版社,2011. |
|
|
|